Skip to content

The Accuracy of Digital Assessment of Performance Trial; the ADAPT Study

The Accuracy of Digital Assessment of Performance Trial; the ADAPT Study - the ADAPT study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON52000
Enrollment
300
Registered
2021-11-17
Start date
2021-12-22
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD Parkinson's disease

Interventions

None listed

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: People with either COPD or Parkinson's disease (PD), able to walk independently and have a indication for physiotherapy

Exclusion criteria

Exclusion criteria: Having fallen more than once within the last 3 months Unstable heart condition

Design outcomes

Primary

MeasureTime frame
1) Difference between in-clinic 6MWT distance and free-living data based 6MWT distance estimate and 2) Difference between in-clinic 6MWT distance and Virtual 6MWT distance estimate

Secondary

MeasureTime frame
1) Difference between in-clinic TUG time and free-living data based TUG time estimate, 2) Difference between in-clinical TUG time and Virtual TUG time estimate and 3) Test-retest agreement across various estimates from each algorithm that is validated

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)